David Einhorn's position in Nuvation Bio is currently worth $165k. That's 0.01% of their equity portfolio (36th largest holding). David Einhorn started to build up the position in Nuvation Bio in Q1 2021. Since then they sold 115k shares. The investor's estimated purchase price is $401k, resulting in a loss of 59%.